Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""COVID-19"" wg kryterium: Temat


Tytuł:
Mass Screening of SARS-CoV-2 With Rapid Antigen Tests in a Receding Omicron Wave: Population-Based Survey for Epidemiologic Evaluation.
Autorzy:
Kwan TH; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong.
Wong NS; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong.; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
Chan CP; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
Yeoh EK; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
Wong SY; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
Lee SS; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong.
Pokaż więcej
Źródło:
JMIR public health and surveillance [JMIR Public Health Surveill] 2022 Nov 09; Vol. 8 (11), pp. e40175. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*/diagnosis
COVID-19*/epidemiology
Female ; Humans ; Male ; COVID-19 Testing ; Cross-Sectional Studies ; COVID-19 Vaccines ; Mass Screening
Czasopismo naukowe
Tytuł:
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.
Autorzy:
Mues KE; Aetion, Inc, 5 Pennsylvania Plaza, New York, NY 10001, USA. Electronic address: .
Kirk B; Aetion, Inc, 5 Pennsylvania Plaza, New York, NY 10001, USA.
Patel DA; Aetion, Inc, 5 Pennsylvania Plaza, New York, NY 10001, USA.
Gelman A; Aetion, Inc, 5 Pennsylvania Plaza, New York, NY 10001, USA.
Chavers LS; Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, USA.
Talarico CA; Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, USA.
Esposito DB; Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, USA.
Martin D; Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, USA.
Mansi J; Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, USA.
Chen X; Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, USA.
Gatto NM; Aetion, Inc, 5 Pennsylvania Plaza, New York, NY 10001, USA.
Van de Velde N; Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, USA.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2022 Nov 08; Vol. 40 (47), pp. 6730-6739. Date of Electronic Publication: 2022 Sep 24.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Adult ; United States/epidemiology ; Humans ; Female ; Middle Aged ; Male ; 2019-nCoV Vaccine mRNA-1273 ; BNT162 Vaccine ; COVID-19 Vaccines ; COVID-19 Testing
Czasopismo naukowe
Tytuł:
A longitudinal study of COVID-19 disclosure stigma and COVID-19 testing hesitancy in the United States.
Autorzy:
Dayton L; Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, USA. Electronic address: .
Song W; Department of Applied Mathematics and Statistics, Johns Hopkins University, USA.
Kaloustian I; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA.
Eschliman EL; Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, USA.
Strickland JC; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, USA.
Latkin C; Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, USA.
Pokaż więcej
Źródło:
Public health [Public Health] 2022 Nov; Vol. 212, pp. 14-21. Date of Electronic Publication: 2022 Aug 26.
Typ publikacji:
Journal Article
MeSH Terms:
Disclosure*
COVID-19*/diagnosis
Female ; Humans ; United States/epidemiology ; Longitudinal Studies ; COVID-19 Testing ; COVID-19 Vaccines
Czasopismo naukowe
Tytuł:
Differences in the Perceived Likelihood of Receiving COVID-19 Vaccine.
Autorzy:
Adzrago D; Center for Health Promotion and Prevention Research, The University of Texas School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Sulley S; National Healthy Start Association, Washington, DC 20005, USA.
Ormiston CK; Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD 20892, USA.
Mamudu L; Department of Public Health, California State University, Fullerton, CA 92831, USA.
Williams F; Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD 20892, USA.
Pokaż więcej
Źródło:
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Oct 22; Vol. 19 (21). Date of Electronic Publication: 2022 Oct 22.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*/therapeutic use
COVID-19*/epidemiology
COVID-19*/prevention & control
Adult ; United States/epidemiology ; Humans ; Cross-Sectional Studies ; COVID-19 Testing ; Vaccination
Czasopismo naukowe
Tytuł:
A Community-Based Participatory Research Approach to Developing and Testing Social and Behavioural Interventions to Reduce the Spread of SARS-CoV-2: A Protocol for the ' COPAR for COVID ' Programme of Research with Five Interconnected Studies in the Hong Kong Context.
Autorzy:
Molassiotis A; School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.; Health and Social Care Research Centre, University of Derby, Derby DE22 1GB, UK.
Xie YJ; School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Leung AYM; School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Ho GWK; School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Li Y; School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Leung PH; Department of Health Technology & Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Wang HL; Department of Family Medicine and Primary Healthcare, Hong Kong West Cluster, Hospital Authority, Hong Kong SAR, China.
Chen CXR; Queen Elisabeth Hospital, Hong Kong SAR, China.
Tong DWK; Hospital Authority, Hong Kong SAR, China.
Siu JY; Department of Applied Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Lau JTF; Centre for Health Behaviours Research, Jockey Club School of Public Health & Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
Pokaż więcej
Źródło:
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Oct 17; Vol. 19 (20). Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Child ; Humans ; Aged ; SARS-CoV-2 ; Community-Based Participatory Research ; COVID-19 Vaccines ; Hong Kong/epidemiology ; COVID-19 Testing ; Chronic Disease
Czasopismo naukowe
Tytuł:
Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica.
Autorzy:
Fantin R; Centro Centroamericano de Población, Universidad de Costa Rica, San José, 2060, Costa Rica. .; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica. .
Herrero R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica.
Hildesheim A; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica.
Barboza-Solís C; Facultad de Odontología, Universidad de Costa Rica, San José, Costa Rica.
Aparicio A; Centro de Desarrollo Estratégico e Información en Salud y Seguridad Social (CENDEISSS) Caja Costarricense de Seguro Social, San José, Costa Rica.
Prevots DR; Epidemiology and Population Studies Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
Pfeiffer RM; Biostatistics Branch, Division of Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Gail MH; Biostatistics Branch, Division of Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. .; Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive RM 7-E138, MSC 9780, Bethesda, MD, 20892, USA. .
Pokaż więcej
Corporate Authors:
RESPIRA Study Group
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Oct 02; Vol. 22 (1), pp. 767. Date of Electronic Publication: 2022 Oct 02.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Testing ; COVID-19 Vaccines ; Costa Rica/epidemiology ; Hospitalization ; Humans ; SARS-CoV-2/genetics ; Vaccine Efficacy
Czasopismo naukowe
Tytuł:
Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination.
Autorzy:
Miyashita N; First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan. Electronic address: .
Nakamori Y; Department of Emergency Medicine, Kansai Medical University Medical Center, Japan.
Ogata M; First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.
Fukuda N; First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.
Yamura A; First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.
Ishiura Y; First Department of Internal Medicine, Division of Respiratory Medicine, Oncology and Allergology, Kansai Medical University Medical Center, Japan.
Nomura S; First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.
Pokaż więcej
Źródło:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2022 Oct; Vol. 28 (10), pp. 1375-1379. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/prevention & control
Community-Acquired Infections*/microbiology
Pneumonia, Mycoplasma*/diagnosis
Aged ; COVID-19 Testing ; COVID-19 Vaccines ; Humans ; Middle Aged ; SARS-CoV-2 ; Sensitivity and Specificity ; Vaccination
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study.
Autorzy:
Omeish H; Department of Internal Medicine, Royal Jordanian Medical Centre- Amman-Jordan.
Najadat A; Department of Internal Medicine, Royal Jordanian Medical Centre- Amman-Jordan.
Al-Azzam S; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Tarabin N; Department of Medicine, Jordan University Hospital, Amman, Jordan.
Abu Hameed A; Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Al-Gallab N; Faculty of Medicine, University of Jordan, Amman, Jordan.
Abbas H; Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Rababah L; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Rabadi M; Department of Dentistry, Ministry of Health, Amman, Jordan.
Karasneh R; Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Aldeyab MA; Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1981086. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
COVID-19 Vaccines/adverse effects ; Cross-Sectional Studies ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
Autorzy:
Link-Gelles R
Ciesla AA
Fleming-Dutra KE
Smith ZR
Britton A
Wiegand RE
Miller JD
Accorsi EK
Schrag SJ
Verani JR
Shang N
Derado G
Pilishvili T
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Dec 02; Vol. 71 (48), pp. 1526-1530. Date of Electronic Publication: 2022 Dec 02.
Typ publikacji:
Practice Guideline; Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*/epidemiology
COVID-19*/prevention & control
United States/epidemiology ; Adult ; Child ; Humans ; Adolescent ; Vaccines, Combined ; COVID-19 Vaccines ; RNA, Messenger ; COVID-19 Testing ; mRNA Vaccines
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.
Autorzy:
Fernandes Q; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar.
Inchakalody VP; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Merhi M; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Mestiri S; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Taib N; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Moustafa Abo El-Ella D; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Bedhiafi T; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Raza A; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Al-Zaidan L; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Mohsen MO; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Research, Immunology RIA, University of Bern, Bern, Switzerland.
Yousuf Al-Nesf MA; Allergy and Immunology Section, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Hssain AA; Medical Intensive Care Unit, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Yassine HM; Qatar University Biomedical Research Center, Qatar University, Doha, Qatar.
Bachmann MF; Department of Biomedical Research, Immunology RIA, University of Bern, Bern, Switzerland.; Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, United Kingdom.
Uddin S; Translational Research Institute and Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Dermime S; Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Pokaż więcej
Źródło:
Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 524-540.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
COVID-19*
Vaccines*
COVID-19 Testing ; COVID-19 Vaccines ; Humans ; SARS-CoV-2
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
Autorzy:
Turbyfill C; CDC COVID-19 Emergency Response Team, Atlanta, GA, United States.
Adams K; CDC COVID-19 Emergency Response Team, Atlanta, GA, United States. Electronic address: .
Tenforde MW; CDC COVID-19 Emergency Response Team, Atlanta, GA, United States.
Murray NL; CDC COVID-19 Emergency Response Team, Atlanta, GA, United States.
Gaglani M; Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, TX, United States.
Ginde AA; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, United States.
McNeal T; Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, TX, United States.
Ghamande S; Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, TX, United States.
Douin DJ; Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO, United States.
Keipp Talbot H; Departments of Medicine and Health Policy, Vanderbilt University Medical Center, Nashville, TN, United States.
Casey JD; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Mohr NM; Department of Emergency Medicine, University of Iowa, Iowa City, IA, United States.
Zepeski A; Department of Emergency Medicine, University of Iowa, Iowa City, IA, United States.
Shapiro NI; Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Gibbs KW; Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Clark Files D; Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Hager DN; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Shehu A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Prekker ME; Department of Emergency Medicine and Medicine, Hennepin County Medical Center, Minneapolis, MN, United States.
Frosch AE; Department of Medicine, Hennepin County Medical Center, Minneapolis, MN, United States.
Exline MC; Department of Medicine, The Ohio State University, Columbus, OH, United States.
Gong MN; Department of Medicine, Montefiore Health System, Albert Einstein College of Medicine, Bronx, NY, United States.
Mohamed A; Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States.
Johnson NJ; Department of Emergency Medicine and Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, United States.
Srinivasan V; Department of Emergency Medicine and Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, United States.
Steingrub JS; Department of Medicine, Baystate Medical Center, Springfield, MA, United States.
Peltan ID; Department of Medicine, Intermountain Medical Center, Murray, Utah and University of Utah, Salt Lake City, UT, United States.
Brown SM; Department of Medicine, Intermountain Medical Center, Murray, Utah and University of Utah, Salt Lake City, UT, United States.
Martin ET; School of Public Health, University of Michigan, Ann Arbor, MI, United States.
Lauring AS; Departments of Internal Medicine and Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States.
Khan A; Department of Medicine, Oregon Health and Sciences University, Portland, OR, United States.
Busse LW; Department of Medicine, Emory University, Atlanta, GA, United States.
Ten Lohuis CC; Emory Critical Care Center, Emory Healthcare, Atlanta, GA, United States.
Duggal A; Department of Medicine, Cleveland Clinic, Cleveland, OH, United States.
Wilson JG; Department of Emergency Medicine, Stanford University School of Medicine, Stanford, CA, United States.
June Gordon A; Department of Emergency Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Qadir N; Department of Medicine, University of California-Los Angeles, Los Angeles, CA, United States.
Chang SY; Department of Medicine, University of California-Los Angeles, Los Angeles, CA, United States.
Mallow C; Department of Medicine, University of Miami, Miami, FL, United States.
Rivas C; Department of Medicine, University of Miami, Miami, FL, United States.
Kwon JH; Department of Medicine, Washington University, St. Louis, MO, United States.
Halasa N; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.
Chappell JD; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.
Grijalva CG; Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, United States.
Rice TW; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Stubblefield WB; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Baughman A; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Rhoads JP; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.
Lindsell CJ; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States.
Hart KW; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States.
McMorrow M; CDC COVID-19 Emergency Response Team, Atlanta, GA, United States.
Surie D; CDC COVID-19 Emergency Response Team, Atlanta, GA, United States.
Self WH; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.
Patel MM; CDC COVID-19 Emergency Response Team, Atlanta, GA, United States.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2022 Nov 15; Vol. 40 (48), pp. 6979-6986. Date of Electronic Publication: 2022 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
COVID-19*/prevention & control
Influenza Vaccines*
Humans ; Adult ; United States/epidemiology ; COVID-19 Vaccines ; SARS-CoV-2 ; COVID-19 Testing ; Vaccine Efficacy ; Case-Control Studies ; Hospitalization ; Syndrome
Czasopismo naukowe
Tytuł:
Factors Associated With the Intention to Receive the COVID-19 Vaccine: Cross-sectional National Study.
Autorzy:
Kasting ML; Department of Public Health, Purdue University, West Lafayette, IN, United States.; Cancer Prevention and Control Program, Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, United States.
Macy JT; Department of Applied Health Science, School of Public Health, Indiana University, Bloomington, IN, United States.
Grannis SJ; Department of Family Medicine, School of Medicine, Indiana University, Indianapolis, IN, United States.; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN, United States.
Wiensch AJ; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN, United States.
Lavista Ferres JM; AI for Good Research Lab, Microsoft Corporation, Redmond, WA, United States.
Dixon BE; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN, United States.; Richard M Fairbanks School of Public Health, Indiana University, Indianapolis, IN, United States.; Center for Health Information and Communication, Health Services Research & Development Service, Richard L Roudebush VA Medical Center, Veterans Health Administration, Indianapolis, IN, United States.
Pokaż więcej
Źródło:
JMIR public health and surveillance [JMIR Public Health Surveill] 2022 Nov 14; Vol. 8 (11), pp. e37203. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Adult ; Male ; United States/epidemiology ; Humans ; Female ; COVID-19 Vaccines ; Pandemics/prevention & control ; Intention ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy.
Autorzy:
Corrao G; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Via Bicocca degli Arcimboldi, 8, Edificio U7, 20126, Milan, Italy.; Directorate General for Health, Lombardy Region, Milan, Italy.
Franchi M; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy. .; Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Via Bicocca degli Arcimboldi, 8, Edificio U7, 20126, Milan, Italy. .
Cereda D; Directorate General for Health, Lombardy Region, Milan, Italy.
Bortolan F; Directorate General for Health, Lombardy Region, Milan, Italy.
Leoni O; Directorate General for Health, Lombardy Region, Milan, Italy.
Vignati E; Welfare Councillor Staff, Lombardy Region, 20124, Milan, Italy.
Pavesi G; Directorate General for Health, Lombardy Region, Milan, Italy.
Gori A; Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Nov 12; Vol. 22 (1), pp. 844. Date of Electronic Publication: 2022 Nov 12.
Typ publikacji:
Journal Article
MeSH Terms:
Myocarditis*/epidemiology
Myocarditis*/etiology
COVID-19*/epidemiology
COVID-19*/prevention & control
Pericarditis*/epidemiology
Pericarditis*/etiology
Male ; Humans ; Adolescent ; Young Adult ; Adult ; Cohort Studies ; COVID-19 Vaccines/adverse effects ; Retrospective Studies ; Vaccination/adverse effects ; Italy/epidemiology
Czasopismo naukowe
Tytuł:
Education-related inequalities in beliefs and behaviors pertaining to COVID-19 non-pharmaceutical interventions.
Autorzy:
Kirkby K; Division of Data, Analytics and Delivery for Impact, Department of Data and Analytics, World Health Organization, 20, Avenue Appia, CH-1211, Geneva, Switzerland.
Bergen N; Division of Data, Analytics and Delivery for Impact, Department of Data and Analytics, World Health Organization, 20, Avenue Appia, CH-1211, Geneva, Switzerland.
Vidal Fuertes C; Division of Data, Analytics and Delivery for Impact, Department of Data and Analytics, World Health Organization, 20, Avenue Appia, CH-1211, Geneva, Switzerland.
Schlotheuber A; Division of Data, Analytics and Delivery for Impact, Department of Data and Analytics, World Health Organization, 20, Avenue Appia, CH-1211, Geneva, Switzerland.
Hosseinpoor AR; Division of Data, Analytics and Delivery for Impact, Department of Data and Analytics, World Health Organization, 20, Avenue Appia, CH-1211, Geneva, Switzerland. .
Pokaż więcej
Źródło:
International journal for equity in health [Int J Equity Health] 2022 Nov 10; Vol. 21 (Suppl 3), pp. 158. Date of Electronic Publication: 2022 Nov 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Pandemics/prevention & control ; COVID-19 Testing ; Educational Status ; Socioeconomic Factors
Czasopismo naukowe
Tytuł:
High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron.
Autorzy:
Baum U; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00300, Helsinki, Finland.
Poukka E; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00300, Helsinki, Finland. .; Faculty of Medicine, University of Helsinki, Helsinki, Finland. .
Leino T; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00300, Helsinki, Finland.
Kilpi T; Management, Research, Development and Innovation, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Nohynek H; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00300, Helsinki, Finland.
Palmu AA; Population Health Unit, Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Tampere, Finland.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Nov 05; Vol. 22 (1), pp. 816. Date of Electronic Publication: 2022 Nov 05.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Aged ; Humans ; Aged, 80 and over ; COVID-19 Vaccines ; Finland/epidemiology ; Vaccine Efficacy ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Impact of COVID-19 on HIV services and anticipated benefits of vaccination in restoring HIV services in Ethiopia: A qualitative assessment.
Autorzy:
Amhare AF; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.; College of Health Science, Salale University, Fiche, Ethiopia.
Zhao M; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.
Seeley J; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Zhang WH; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.; School of Public Health, Université Libre de Bruxelles, Brussels, Belgium.
Goyomsa GG; College of Health Science, Salale University, Fiche, Ethiopia.
Geleta TA; College of Health Science, Salale University, Fiche, Ethiopia.
Zhao R; School of Humanities and Management, Institute of Life Culture, Guangdong Medical University, Dongguan, China.
Zhang L; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.; Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia.; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Pokaż więcej
Źródło:
Frontiers in public health [Front Public Health] 2022 Nov 03; Vol. 10, pp. 1033351. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
HIV Infections*/epidemiology
HIV Infections*/therapy
Humans ; Ethiopia/epidemiology ; COVID-19 Vaccines ; Pandemics ; Vaccination
Czasopismo naukowe
Tytuł:
An Analysis of the COVID-19 Situation in India in Terms of Testing, Treatment, Vaccine Acceptance and National Economic Performance.
Autorzy:
Patel RB; Department of Bioscience, Indrashil University, Rajpur, India.
Patel BB; Department of General Surgery, GMERS Medical College and Civil Hospital, Gandhinagar, India.
Pokaż więcej
Źródło:
International journal of public health [Int J Public Health] 2022 Nov 02; Vol. 67, pp. 1604975. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Humans ; Pandemics/prevention & control ; COVID-19 Testing ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Characteristics Associated With a Previous COVID-19 Diagnosis, Vaccine Uptake, and Intention to Be Vaccinated Among Essential Workers in the US Household Pulse Survey.
Autorzy:
Steege AL; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Luckhaupt SE; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Guerin RJ; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Okun AH; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Hung MC; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Syamlal G; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Lu PJ; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Santibanez TA; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Groenewold MR; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Billock R; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Singleton JA; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Sweeney MH; At the time of this study, all of the authors were with the Centers for Disease Control and Prevention (CDC) COVID-19 Response, Atlanta, GA.
Pokaż więcej
Źródło:
American journal of public health [Am J Public Health] 2022 Nov; Vol. 112 (11), pp. 1599-1610.
Typ publikacji:
Journal Article
MeSH Terms:
AIDS Vaccines*
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza Vaccines*
Papillomavirus Vaccines*
Respiratory Syncytial Virus Vaccines*
SAIDS Vaccines*
Adult ; BCG Vaccine ; COVID-19 Testing ; COVID-19 Vaccines ; Diphtheria-Tetanus-Pertussis Vaccine ; Humans ; Intention ; Measles-Mumps-Rubella Vaccine ; Vaccination
Czasopismo naukowe
Tytuł:
COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.
Autorzy:
Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Delgado-Sanz C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Monge S; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Infectious Diseases (CIBERINFEC), Madrid, Spain.
Pozo F; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
Oliva J; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Sandonis V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
Gandarillas A; Subdirección General de Epidemiología, Dirección General de Salud Pública, Madrid, Spain.
Quiñones-Rubio C; Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, Logroño, Spain.
Ruiz-Sopeña C; Dirección General de Salud Pública, Junta de Castilla y León, Valladolid, Spain.
Gallardo-García V; Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Seville, Spain.
Basile L; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalonia, Spain.
Barranco-Boada MI; Servicio de Epidemiología, Dirección General de Salud Pública, Consejería de Salud, Murcia, Spain.
Hidalgo-Pardo O; Servicio de Medicina Preventiva Hospital Universitario Son Espases, Servicio de Epidemiología, Consellería de Salut, Palma, Spain.
Vazquez-Cancela O; Servicio de Medicina Preventiva, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
García-Vázquez M; Vigilancia Epidemiológica, Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Fernández-Sierra A; Servicio Medicina Preventiva, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Milagro-Beamonte A; Laboratorio de Microbiología, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
Ordobás M; Subdirección General de Epidemiología, Dirección General de Salud Pública, Madrid, Spain.
Martínez-Ochoa E; Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, Logroño, Spain.
Fernández-Arribas S; Dirección General de Salud Pública, Junta de Castilla y León, Valladolid, Spain.
Lorusso N; Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Seville, Spain.
Martínez A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalonia, Spain.
García-Fulgueiras A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Servicio de Epidemiología, Dirección General de Salud Pública, Consejería de Salud, Murcia, Spain.
Sastre-Palou B; Servicio de Medicina Preventiva Hospital Universitario Son Espases, Servicio de Epidemiología, Consellería de Salut, Palma, Spain.
Losada-Castillo I; Servizo de Epidemioloxía, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, Spain.
Martínez-Cuenca S; Vigilancia Epidemiológica, Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Rodríguez-Del Águila M; Servicio Medicina Preventiva, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Latorre M; Laboratorio de Microbiología, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
Larrauri A; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Pokaż więcej
Corporate Authors:
SARI surveillance VE group in Spain
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Nov; Vol. 16 (6), pp. 1014-1025. Date of Electronic Publication: 2022 Jul 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Respiratory Tract Infections*/epidemiology
Respiratory Tract Infections*/prevention & control
COVID-19 Vaccines ; Hospitalization ; Humans ; SARS-CoV-2/genetics ; Sentinel Surveillance ; Spain/epidemiology ; Vaccine Efficacy
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Clinical presentations of adult and pediatric SARS-CoV-2-positive cases in a community cohort, Nashville, Tennessee.
Autorzy:
Rankin DA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Vanderbilt Epidemiology PhD Program, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Yanis A; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Talj R; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Howe HL; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Bloos SM; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Tulane University School of Medicine, Tulane University, New Orleans, Louisiana, USA.
Fernandez KN; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Amarin JZ; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Bruce M; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Salib S; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Hargrave S; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Chappell JD; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Spieker AJ; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Halasa NB; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Howard LM; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2022 Nov; Vol. 94 (11), pp. 5560-5566. Date of Electronic Publication: 2022 Jul 21.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/epidemiology
SARS-CoV-2*
Adult ; COVID-19 Testing ; Child ; Humans ; Longitudinal Studies ; Tennessee/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz